Skip to main content

Advertisement

Log in

The Association Between Chronic Lymphocytic Thyroiditis and the Progress of Papillary Thyroid Cancer

  • Original Scientific Report
  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

Whether chronic lymphocytic thyroiditis (CLT) influences the risk of development and the progression of papillary thyroid cancer (PTC) remains uncertain. We investigated the effects of CLT on the clinicopathologic features and prognosis of PTC.

Methods

Two thousand nine hundred twenty-eight consecutive patients with PTC treated between 2009 and 2017 were divided into two groups: one with chronic lymphocytic thyroiditis and one without; 1174 (40%) of the patients had coincident CLT.

Results

In univariate analysis, CLT correlated positively with small tumor size, frequent extrathyroidal extension, multifocal diseases, and p53 but negatively with central lymph node (LN) metastasis and BRAF mutation. In multivariate analysis, CLT was associated with extrathyroidal extension and multifocal disease; however, it was not a prognostic factor for recurrence even though it was associated with two aggressive factors. Compared with patients with PTC alone, there were more retrieved central LNs in the PTC + CLT group, and these patients also underwent more invasive diagnostic tests such as fine needle aspiration cytology and frozen biopsy of LN.

Conclusions

The CLT patients with PTC had better behavior features and prognoses than did those with PTC alone despite frequent multifocality and extrathyroidal extension. However, precaution may be necessary to avoid performing invasive diagnostic procedures for lateral LN metastasis and to manage the patients appropriately.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Parkin DM, Bray F, Ferlay J et al (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108

    Article  Google Scholar 

  2. Albores-Saavedra J, Henson DE, Glazer E et al (2007) Changing patterns in the incidence and survival of thyroid cancer with follicular phenotype—papillary, follicular, and anaplastic: a morphological and epidemiological study. Endocr Pathol 18:1–7

    Article  Google Scholar 

  3. Consorti F, Loponte M, Milazzo F et al (2010) Risk of malignancy from thyroid nodular disease as an element of clinical management of patients with Hashimoto's thyroiditis. Eur Surg Res 45:333–337

    Article  CAS  Google Scholar 

  4. Repplinger D, Bargren A, Zhang YW et al (2008) Is Hashimoto's thyroiditis a risk factor for papillary thyroid cancer? J Surg Res 150:49–52

    Article  Google Scholar 

  5. Pearce EN, Farwell AP, Braverman LE (2003) Thyroiditis. N Engl J Med 348:2646–2655

    Article  Google Scholar 

  6. Jankovic B, Le KT, Hershman JM (2013) Clinical review: Hashimoto's thyroiditis and papillary thyroid carcinoma: is there a correlation? J Clin Endocrinol Metab 98:474–482

    Article  CAS  Google Scholar 

  7. Gorges R, Maniecki M, Jentzen W et al (2005) Development and clinical impact of thyroglobulin antibodies in patients with differentiated thyroid carcinoma during the first 3 years after thyroidectomy. Eur J Endocrinol 153:49–55

    Article  CAS  Google Scholar 

  8. Tozzoli R, Bizzaro N, Tonutti E et al (2002) Immunoassay of anti-thyroid autoantibodies: high analytical variability in second generation methods. Clin Chem Lab Med 40:568–573

    Article  CAS  Google Scholar 

  9. Bhatia A, Rajwanshi A, Dash RJ et al (2007) Lymphocytic thyroiditis—is cytological grading significant? A correlation of grades with clinical, biochemical, ultrasonographic and radionuclide parameters. CytoJournal 4:10

    Article  Google Scholar 

  10. Bohuslavizki KH, vom Baur E, Weger B et al (2000) Evaluation of chemiluminescence immunoassays for detecting thyroglobulin (Tg) and thyroid peroxidase (TPO) autoantibodies using the IMMULITE 2000 system. Clin Lab 46:23–31

    CAS  PubMed  Google Scholar 

  11. Sapin R, d'Herbomez M, Gasser F et al (2003) Increased sensitivity of a new assay for anti-thyroglobulin antibody detection in patients with autoimmune thyroid disease. Clin Biochem 36:611–616

    Article  CAS  Google Scholar 

  12. La'ulu SL, Slev PR, Roberts WL (2007) Performance characteristics of 5 automated thyroglobulin autoantibody and thyroid peroxidase autoantibody assays. Clin Chim Acta 376:88–95

    Article  CAS  Google Scholar 

  13. Lai X, Xia Y, Zhang B et al (2017) A meta-analysis of Hashimoto's thyroiditis and papillary thyroid carcinoma risk. Oncotarget 8:62414–62424

    PubMed  PubMed Central  Google Scholar 

  14. Brierley JD, Gospodarowicz MK, Wittekind C (eds) (2017) TNM classification of malignant tumours, 8th edn. Wiley, Hoboken

    Google Scholar 

  15. Tomari S, Watanabe M, Inoue N et al (2017) The polymorphisms in the thyroid peroxidase gene were associated with the development of autoimmune thyroid disease and the serum levels of anti-thyroid peroxidase antibody. Endocr J 64:1025–1032

    Article  CAS  Google Scholar 

  16. Iwatani Y, Amino N, Mori H et al (1983) T lymphocyte subsets in autoimmune thyroid diseases and subacute thyroiditis detected with monoclonal antibodies. J Clin Endocrinol Metab 56:251–254

    Article  CAS  Google Scholar 

  17. Asa SL (2004) My approach to oncocytic tumours of the thyroid. J Clin Pathol 57:225–232

    Article  CAS  Google Scholar 

  18. Vanderpump MP, Tunbridge WM, French JM et al (1995) The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 43:55–68

    Article  CAS  Google Scholar 

  19. Liu Y, Li C, Zhao W et al (2017) Hashimoto's thyroiditis is an important risk factor of papillary thyroid microcarcinoma in younger adults. Horm Metab Res 49:732–738

    Article  CAS  Google Scholar 

  20. Zaydfudim V, Feurer ID, Griffin MR et al (2008) The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma. Surgery 144:1070–1077 (discussion 1077–1078)

    Article  Google Scholar 

  21. Yoo YH, Kim JA, Son EJ et al (2013) Sonographic findings predictive of central lymph node metastasis in patients with papillary thyroid carcinoma: influence of associated chronic lymphocytic thyroiditis on the diagnostic performance of sonography. J Ultrasound Med 32:2145–2151

    Article  Google Scholar 

  22. Babli S, Payne RJ, Mitmaker E et al (2018) Effects of chronic lymphocytic thyroiditis on the clinicopathological features of papillary thyroid cancer. Eur Thyroid J 7:95–101

    Article  Google Scholar 

  23. Zhu F, Shen YB, Li FQ et al (2016) The effects of Hashimoto thyroiditis on lymph node metastases in unifocal and multifocal papillary thyroid carcinoma: a retrospective Chinese cohort study. Medicine (Baltimore) 95:e2674

    Article  CAS  Google Scholar 

  24. Yoon YH, Kim HJ, Lee JW et al (2012) The clinicopathologic differences in papillary thyroid carcinoma with or without co-existing chronic lymphocytic thyroiditis. Eur Arch Otorhinolaryngol 269:1013–1017

    Article  Google Scholar 

  25. Girardi FM, Barra MB, Zettler CG (2015) Papillary thyroid carcinoma: does the association with Hashimoto's thyroiditis affect the clinicopathological characteristics of the disease? Braz J Otorhinolaryngol 81:283–287

    Article  Google Scholar 

  26. Del Rio P, Cataldo S, Sommaruga L et al (2008) The association between papillary carcinoma and chronic lymphocytic thyroiditis: does it modify the prognosis of cancer? Minerva Endocrinol 33:1–5

    PubMed  Google Scholar 

  27. Liu Z, Wang L, Yi P et al (2014) Risk factors for central lymph node metastasis of patients with papillary thyroid microcarcinoma: a meta-analysis. Int J Clin Exp Pathol 7:932–937

    PubMed  PubMed Central  Google Scholar 

  28. Asanuma K, Sugenoya A, Kasuga Y et al (1998) The relationship between multiple intrathyroidal involvement in papillary thyroid carcinoma and chronic non-specific thyroiditis. Cancer Lett 122:177–180

    Article  CAS  Google Scholar 

  29. Ehlers M, Schott M (2014) Hashimoto's thyroiditis and papillary thyroid cancer: are they immunologically linked? Trends Endocrinol Metab 25:656–664

    Article  CAS  Google Scholar 

  30. Giordano C, Stassi G, De Maria R et al (1997) Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 275:960–963

    Article  CAS  Google Scholar 

  31. Han PA, Kim HS, Cho S et al (2016) Association of BRAF V600E mutation and microRNA expression with central lymph node metastases in papillary thyroid cancer: a prospective study from four endocrine surgery centers. Thyroid 26:532–542

    Article  Google Scholar 

  32. Ouyang B, Knauf JA, Smith EP et al (2006) Inhibitors of Raf kinase activity block growth of thyroid cancer cells with RET/PTC or BRAF mutations in vitro and in vivo. Clin Cancer Res 12:1785–1793

    Article  CAS  Google Scholar 

  33. Kim SK, Song KH, Lim SD et al (2009) Clinical and pathological features and the BRAF(V600E) mutation in patients with papillary thyroid carcinoma with and without concurrent Hashimoto thyroiditis. Thyroid 19:137–141

    Article  Google Scholar 

  34. Muzza M, Degl'Innocenti D, Colombo C et al (2010) The tight relationship between papillary thyroid cancer, autoimmunity and inflammation: clinical and molecular studies. Clin Endocrinol (Oxf) 72:702–708

    Article  CAS  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jeonghun Lee.

Ethics declarations

Conflict of interest

This work was supported by the new faculty research fund of Ajou University School of Medicine.

Informed consent

Informed consent was not obtained because of the retrospective chart review study design and use of only deidentified clinicopathological information. The study protocol was approved by the Institutional Review Board of Ajou Medical Centre (AJIRB-MED-MDB-19-090).

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lee, I., Kim, H.K., Soh, E.Y. et al. The Association Between Chronic Lymphocytic Thyroiditis and the Progress of Papillary Thyroid Cancer. World J Surg 44, 1506–1513 (2020). https://doi.org/10.1007/s00268-019-05337-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-019-05337-9

Navigation